Anthony E. Maida III - Chief Clin. Ops. Officer, Director at Oncotelic Therapeutics, Inc.

Issuer-level insider activity

Role
Chief Clin. Ops. Officer, Director
Issuer symbol
OTLC on OTC
Identity 1 fact
Entity type
Individual
SEC evidence 1 fact
Source evidence
Open source filing history

No buys or sells have been reported by Anthony E. Maida III since 01 Jun 2025

Reported holdings for Anthony E. Maida III in Oncotelic Therapeutics, Inc.

Form 4 holding Chief Clin. Ops. Officer, Director

Oncotelic Therapeutics, Inc.

Security class
Stock Options
Shares / value
600,000
Estimated value
Report date
03 Sep 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Anthony E. Maida III in Oncotelic Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .